MYPT1, an acronym for "Myosin Phosphatase Target Subunit 1", is an integral protein involved in the regulation of myosin light chain (MLC) phosphorylation within cells. Myosin is a motor protein crucial for several cellular processes, including muscle contraction and cell motility. Phosphorylation of MLC, a component of myosin, is a key regulatory step that modulates its activity. MYPT1 acts as a targeting subunit for myosin light chain phosphatase (MLCP), directing MLCP to its substrate, the phosphorylated MLC, thereby mediating its dephosphorylation. This action makes MYPT1 a crucial player in determining the phosphorylation status of MLC, which in turn affects cellular activities like muscle relaxation and cell movement.
Activators of MYPT1 are molecules that enhance the function or expression of MYPT1. By increasing the activity or presence of MYPT1, these activators can promote the dephosphorylation of MLC, which can have significant implications for cellular dynamics. An increase in MYPT1 activity can lead to a decrease in phosphorylated MLC, promoting processes like muscle relaxation. On the cellular level, the function of MYPT1 and its regulation can affect processes like cell migration, shape change, and adherence to surfaces. The modulation of MYPT1 activity via activators offers a means to influence these cellular behaviors. Understanding the specific interactions and mechanisms of MYPT1 activators can provide insight into the delicate balance of phosphorylation and dephosphorylation processes within cells and the myriad of cellular functions they influence. The study of these activators is crucial for a comprehensive grasp of the intricate network of cellular signaling and regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor that might directly modulate MYPT1 activity, potentially influencing its expression. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum kinase inhibitor which could influence the kinases regulating MYPT1, potentially modulating its expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, raising cAMP levels and potentially influencing MYPT1 expression through PKA-dependent pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Known to modulate kinase activities and could influence MYPT1 expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates various cellular signaling pathways which might influence MYPT1 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that might influence pathways associated with MYPT1 regulation and expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that could influence cellular signaling pathways associated with MYPT1 expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, which can phosphorylate and regulate MYPT1, potentially influencing its expression. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
PKA inhibitor, potentially modulating pathways influencing MYPT1 expression. | ||||||